ArticleMolecular cancer research : MCR2021

AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer.

Anna C Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.